National study of antibiotic use in emergency department visits for pneumonia, 1993 through 2008

Academic Emergency Medicine

Volumn 19, Issue 5, 2012, Pages 562-568

  Neuman, Mark I ^a   Ting, Sarah A ^b   Meydani, Ahou ^b   Mansbach, Jonathan M ^a   Camargo, Carlos A ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; MACROLIDE; PENICILLIN G; QUINOLONE;

ADULT; AGED; COMMUNITY ACQUIRED PNEUMONIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG USE; EMERGENCY WARD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 84861327154     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2012.01342.x     Document Type: Review

References (39)

1. American Thoracic Society. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis. 1993; 148: 1418-26.
2. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Am J Respir Care Med. 2001; 163: 1730-54.
3. Mandell LA, Wunderink RG, Anzueto A, et al., Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007; 44 (Suppl 2): S27-72.
4. Pham JC, Kelen GD, Pronovost PJ,. National study on the quality of emergency department care in the treatment of acute myocardial infarction and pneumonia. Acad Emerg Med. 2007; 14: 856-63.
5. Pham JC, Ho GK, Hill PM, McCarthy ML, Pronovost PJ,. National study of patient, visit, and hospital characteristics associated with leaving an emergency department without being seen: predicting LWBS. Acad Emerg Med. 2009; 16: 949-55.
6. Tang N, Stein J, Hsia RY, Maselli JH, Gonzales R,. Trends and characteristics of US emergency department visits, 1997-2007. JAMA. 2010; 304: 664-70.
7. Wiler JL, Ross MA, Ginde AA,. National study of emergency department observation services. Acad Emerg Med. 2011; 18: 959-65.
8. Moran GJ,. New directions in antiinfective therapy for community-acquired pneumonia in the emergency department. Pharmacotherapy. 2001; 21 (7 pt 2): 95S-9S.
9. Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R,. The cost of treating community-acquired pneumonia. Clin Ther. 1998; 20: 820-37.
10. Talan DA, Moran GJ,. Emergency department management of pneumonia. Can Respir J. 1999; 6 (Suppl A): 10A-4A.
11. Barrett TW, Schriger DL,. Emergency department crowding is associated with poor care for patients with severe pain. Ann Emerg Med. 2008; 51: 6-7.
12. Bernstein SL, Aronsky D, Duseja R, et al., The effect of emergency department crowding on clinically oriented outcomes. Acad Emerg Med. 2009; 16: 1-10.
13. Fee C, Weber EJ, Maak CA, Bacchetti P,. Effect of emergency department crowding on time to antibiotics in patients admitted with community-acquired pneumonia. Ann Emerg Med. 2007; 50: 501-9.
14. McCaig LF, Burt CW,. National Hospital Ambulatory Medical Care Survey: 1999 emergency department summary. Adv Data. 2001; 320: 1-36.
15. Baine WB, Yu W, Summe JP,. Epidemiologic trends in the hospitalization of elderly Medicare patients for pneumonia, 1991-1998. Am J Public Health. 2001; 91: 1121-3.
16. Henrickson KJ, Kuhn SM, Savatski LL,. Epidemiology and cost of infection with human parainfluenza virus types 1 and 2 in young children. Clin Infect Dis. 1994; 18: 770-9.
17. Marrie TJ,. Pneumococcal pneumonia: epidemiology and clinical features. Semin Respir Infect. 1999; 14: 227-36.
18. Jha AK, Shlipak MG, Hosmer W, Frances CD, Browner WS,. Racial differences in mortality among men hospitalized in the Veterans Affairs health care system. JAMA. 2001; 285: 297-303.
19. McCabe C, Kirchner C, Zhang H, Daley J, Fisman DN,. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med. 2009; 169: 1525-31.
20. Wu JH, Howard DH, McGowan JE Jr, Turpin RS, Henry Hu X,. Adherence to infectious diseases society of America guidelines for empiric therapy for patients with community-acquired pneumonia in a commercially insured cohort. Clin Ther. 2006; 28: 1451-61.
21. Nathwani D, Rubinstein E, Barlow G, Davey P,. Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care? Clin Infect Dis. 2001; 32: 728-41.
22. Schwartz DN, Furumoto-Dawson A, Itokazu GS, Chinikamwala M, Levasseur S, Weinstein RA,. Preventing mismanagement of community-acquired pneumonia at an urban public hospital: implications for institution-specific practice guidelines. Chest. 1998; 113 (3 Suppl): 194S-8S.
23. Meehan TP, Fine MJ, Krumholz HM, et al., Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA. 1997; 278: 2080-4.
24. Dean NC, Silver MP, Bateman KA,. Frequency of subspecialty physician care for elderly patients with community-acquired pneumonia. Chest. 2000; 117: 393-7.
25. Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG,. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA. 2000; 283: 749-55.
26. Mortensen EM, Restrepo M, Anzueto A, Pugh J,. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. Am J Med. 2004; 117: 726-31.
27. Drake DE, Cohen A, Cohn J,. National hospital antibiotic timing measures for pneumonia and antibiotic overuse. Qual Manag Health Care. 2007; 16: 113-22.
28. Friedberg MW, Mehrotra A, Linder JA,. Reporting hospitals' antibiotic timing in pneumonia: adverse consequences for patients? Am J Manag Care. 2009; 15: 137-44.
29. Kanwar M, Brar N, Khatib R, Fakih MG,. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest. 2007; 131: 1865-9.
30. Nawar EW, Niska RW, Xu J,. National Hospital Ambulatory Medical Care Survey: 2005 emergency department summary. Adv Data. 2007; 1-32.
31. Wachter RM, Flanders SA, Fee C, Pronovost PJ,. Public reporting of antibiotic timing in patients with pneumonia: lessons from a flawed performance measure. Ann Intern Med. 2008; 149: 29-32.
32. Van Bambeke F, Reinert RR, Appelbaum PC, Tulkens PM, Peetermans WE,. Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options. Drugs. 2007; 67: 2355-82.
33. Wallin TR, Hern HG, Frazee BW,. Community-associated methicillin- resistant Staphylococcus aureus. Emerg Med Clin North Am. 2008; 26: 431-55.
34. Cunha BA,. Penicillin resistance in pneumococcal pneumonia. Antibiotics with low resistance potential are effective and pose less risk. Postgrad Med. 2003; 113: 42-4 47-8, 52-4.
35. Mandell LA,. Relationship of penicillin resistance to mortality in pneumococcal pneumonia. Curr Infect Dis Rep. 2001; 3: 9-12.
36. Coley KC, Skledar SJ, Fine MJ, et al., Changing physician prescribing behavior: the community-acquired pneumonia intervention trial. Am J Health Syst Pharm. 2000; 57: 1506-10.
37. Whittle J, Fine MJ, Joyce DZ, et al., Community-acquired pneumonia: can it be defined with claims data? Am J Med Qual. 1997; 12: 187-93.
38. Grijalva CG, Nuorti JP, Griffin MR,. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009; 302: 758-66.
39. Pletcher MJ, Kertesz SG, Kohn MA, Gonzales R,. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA. 2008; 299: 70-8.